These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20489414)

  • 21. [How to defuse the diabetes mellitus time bomb: identify early signs and vascular injuries, minimize risk factors].
    Janka HU
    MMW Fortschr Med; 2003 May; 145(21):29-30. PubMed ID: 12845863
    [No Abstract]   [Full Text] [Related]  

  • 22. Reducing cardiovascular risk in type 2 diabetes.
    Solomon CG
    N Engl J Med; 2003 Jan; 348(5):457-9. PubMed ID: 12556548
    [No Abstract]   [Full Text] [Related]  

  • 23. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 25. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP; McMahon GT
    Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond the UKPDS: in search of the optimal strategy for the treatment of type 2 diabetes.
    Riccardi G
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):104-7. PubMed ID: 11006917
    [No Abstract]   [Full Text] [Related]  

  • 29. Diabetes as a 'cardiovascular disease equivalent': implications for treatment.
    Laakso M
    Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):682-3. PubMed ID: 18797431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
    De Taeye B; Smith LH; Vaughan DE
    Curr Opin Pharmacol; 2005 Apr; 5(2):149-54. PubMed ID: 15780823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.
    Cannon CP
    Am J Cardiol; 2008 Dec; 102(12A):5L-9L. PubMed ID: 19084083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes.
    Kadoglou NP; Iliadis F; Liapis CD; Perrea D; Angelopoulou N; Alevizos M
    Diabetes Care; 2007 Sep; 30(9):2242-4. PubMed ID: 17586747
    [No Abstract]   [Full Text] [Related]  

  • 33. [Should we prescribe regular physical activity for patients presenting with type 2 diabetes?].
    Gautier JF
    Diabete Metab; 1994; 20(5):497-500. PubMed ID: 7859899
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B; Maes M; Zambon A
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Metabolic syndrome as a precursor of diabetes mellitus type 2 and cardiovascular diseases].
    Shestakova MV; Butrova SA; Sukhareva OIu
    Ter Arkh; 2007; 79(10):5-8. PubMed ID: 18154136
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucose, insulin, diabetes and mechanisms of arterial dysfunction.
    Cameron JD; Cruickshank JK
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):677-82. PubMed ID: 17581229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of ischemic cardiovascular complications in type 2 diabetes].
    Moulin P
    Journ Annu Diabetol Hotel Dieu; 2000; ():125-37. PubMed ID: 10932875
    [No Abstract]   [Full Text] [Related]  

  • 38. Young at heart. For people with type 2 diabetes, cardiovascular disease is enemy No. 1.
    Curry A
    Diabetes Forecast; 2014 Dec; 67(12):68-9. PubMed ID: 25872369
    [No Abstract]   [Full Text] [Related]  

  • 39. On the importance of global cardiovascular risk assessment in people with type 2 diabetes.
    Echouffo-Tcheugui JB; Kengne AP
    Prim Care Diabetes; 2013 Jul; 7(2):95-102. PubMed ID: 23623209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticipatory care for the diabetic-hypertensive bundle.
    Hart JT
    Prim Care Diabetes; 2008 Dec; 2(4):165-6. PubMed ID: 19008169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.